Language selection

Search

Details for: POMALYST

Company: CELGENE INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02419580POMALYSTPOMALIDOMIDE1 MGCAPSULEORAL
02419599POMALYSTPOMALIDOMIDE2 MGCAPSULEORAL
02419602POMALYSTPOMALIDOMIDE3 MGCAPSULEORAL
02419610POMALYSTPOMALIDOMIDE4 MGCAPSULEORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Basis of Decision
Summary Safety Review - Pomalyst (pomalidomide) and Thalomid (thalidomide) - Assessing the potential risk of Progressive Multifocal Leukoencephalopathy

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: